Explore more publications!
Healthy Living Maldives
Got News to Share?

Healthy Living Maldives: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Maldives.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on September 22, 2025

Cibus CEO to Highlight Gene Editing’s Role in Building Resilient Agriculture at UN Climate Week 2025
September 22, 2025

Cibus CEO to Highlight Gene Editing’s Role in Building Resilient Agriculture at UN Climate Week 2025

Indeterminate GlobeNewswire
Guerbet : Change in General Management
September 22, 2025

Guerbet : Change in General Management

Indeterminate GlobeNewswire
Guerbet : Evolution de la Direction Générale
September 22, 2025

Guerbet : Evolution de la Direction Générale

Indeterminate GlobeNewswire
Humanitarian Nonprofit Human Appeal Canada to Host Second Annual Comedy Tour
September 22, 2025

Humanitarian Nonprofit Human Appeal Canada to Host Second Annual Comedy Tour

Indeterminate GlobeNewswire
Angelini Pharma Signs Exclusive Option Agreement With Sovargen To License Global Development and Commercialization Rights For Innovative Brain Health Asset
September 22, 2025

Angelini Pharma Signs Exclusive Option Agreement With Sovargen To License Global Development and Commercialization Rights For Innovative Brain Health Asset

Indeterminate GlobeNewswire
Angelini Pharma sigla un accordo di opzione esclusiva con Sovargen per ottenere i diritti globali di sviluppo e commercializzazione di un asset innovativo nell'ambito della salute del cervello
September 22, 2025

Angelini Pharma sigla un accordo di opzione esclusiva con Sovargen per ottenere i diritti globali di sviluppo e commercializzazione di un asset innovativo nell'ambito della salute del cervello

Indeterminate GlobeNewswire
InBrain Pharma to Present Long-Term Follow-Up Clinical Data from Its Phase I/II DIVE-I Trial in Parkinson’s Disease at the MDS 2025 Conference
September 22, 2025

InBrain Pharma to Present Long-Term Follow-Up Clinical Data from Its Phase I/II DIVE-I Trial in Parkinson’s Disease at the MDS 2025 Conference

Indeterminate GlobeNewswire
Longeveron® to Attend Alliance for Regenerative Medicine’s Cell & Gene Meeting on the Mesa
September 22, 2025

Longeveron® to Attend Alliance for Regenerative Medicine’s Cell & Gene Meeting on the Mesa

Indeterminate GlobeNewswire
Celcuity to Present Results from the Pivotal Phase 3 VIKTORIA-1 Trial at the 2025 European Society for Medical Oncology (ESMO) Congress
September 22, 2025

Celcuity to Present Results from the Pivotal Phase 3 VIKTORIA-1 Trial at the 2025 European Society for Medical Oncology (ESMO) Congress

Indeterminate GlobeNewswire
NorthStar Moving’s 2025 Let’s Send Hunger Packing Food Drive Provides Nearly 100,000 Meals to LA Children
September 22, 2025

NorthStar Moving’s 2025 Let’s Send Hunger Packing Food Drive Provides Nearly 100,000 Meals to LA Children

Indeterminate GlobeNewswire
Carlsmed, Inc. Selected for Inclusion in Russell 2000® Index
September 22, 2025

Carlsmed, Inc. Selected for Inclusion in Russell 2000® Index

Indeterminate GlobeNewswire
Fierce Biotech names Incyclix Bio a “Fierce 15” Biotech Company of 2025
September 22, 2025

Fierce Biotech names Incyclix Bio a “Fierce 15” Biotech Company of 2025

Indeterminate GlobeNewswire
Crisis Text Line Acquires Aquí Estoy Chat; Plans to Expand Mental Health Support Across Spanish-Speaking Countries: Latin America, Spain, and the Caribbean
September 22, 2025

Crisis Text Line Acquires Aquí Estoy Chat; Plans to Expand Mental Health Support Across Spanish-Speaking Countries: Latin America, Spain, and the Caribbean

Indeterminate GlobeNewswire
Yatiri Bio Receives Grant to Advance Proteomics Interoperability in Cancer Research
September 22, 2025

Yatiri Bio Receives Grant to Advance Proteomics Interoperability in Cancer Research

Indeterminate GlobeNewswire
AIM ImmunoTech Announces Publication of Journal Article On the Positive Effect of Ampligen and Interferon-Alpha on Tumor Growth
September 22, 2025

AIM ImmunoTech Announces Publication of Journal Article On the Positive Effect of Ampligen and Interferon-Alpha on Tumor Growth

Indeterminate GlobeNewswire
WORK Medical Technology Group LTD Partners with Wuxi Branch of Ruijin Hospital-Shanghai Jiao Tong University School of Medicine to Develop AI-Applications in Healthcare
September 22, 2025

WORK Medical Technology Group LTD Partners with Wuxi Branch of Ruijin Hospital-Shanghai Jiao Tong University School of Medicine to Develop AI-Applications in Healthcare

Indeterminate GlobeNewswire
Actuate Therapeutics Provides FDA with Updated Clinical Data Package to Support Planned Regulatory Interactions with FDA and EMA Over the Coming Months
September 22, 2025

Actuate Therapeutics Provides FDA with Updated Clinical Data Package to Support Planned Regulatory Interactions with FDA and EMA Over the Coming Months

Indeterminate GlobeNewswire
NetraMark Initiates AI-Driven Collaboration in Glioblastoma Research
September 22, 2025

NetraMark Initiates AI-Driven Collaboration in Glioblastoma Research

Indeterminate GlobeNewswire
Integra LifeSciences Strengthens Leadership with Appointment of New Chief Medical Officer
September 22, 2025

Integra LifeSciences Strengthens Leadership with Appointment of New Chief Medical Officer

Indeterminate GlobeNewswire
Achieve Life Sciences Announces Publication in Thorax of Data Demonstrating Cytisinicline’s Potential Efficacy and Tolerability for Smoking Cessation in Individuals with COPD
September 22, 2025

Achieve Life Sciences Announces Publication in Thorax of Data Demonstrating Cytisinicline’s Potential Efficacy and Tolerability for Smoking Cessation in Individuals with COPD

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions